Cipla yesterday announced that it has been selected in the S&P Dow Jones Sustainability Index (DJSI) for the Emerging Markets for 2021. The DJSI family of indices is operated by one of the world’s leading index providers S&P Dow Jones. The Emerging Markets Index for the year comprises 108 companies from 12 emerging economies, including China, Brazil, South Africa and Taiwan, according to a statement from the company.
The statement added that as of 12th November, 2021, Cipla performed in the top decile in the pharmaceutical industry in the S&P Global Corporate Sustainability Assessment, with a ranking of 93 percentile in the industry, meaning 93 per cent of companies reached an equal or lower ESG Score.
The company significantly improved performance in parameters like strategy to improve access to drugs or products, human capital development, tax strategy and climate strategy compared to last year, it added.
Commenting on the ranking, Umang Vohra, MD and Global CEO, Cipla, said, “The selection into S&P Dow Jones Sustainability Index Emerging Markets is a testament to our commitment towards sustainability, which is at the core of our DNA. We are delighted to be recognised for our efforts in climate action and social impact, coupled with strong corporate governance. This recognition strengthens our belief in investing in greener technology and processes, creating social impact for communities and serving the markets to create for healthier people and a healthier planet. We remain committed to building ecosystems for accessible and patient-centric quality healthcare, underpinned by industry-leading practices.”